These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9656594)

  • 1. [Vaccination against A-C meningococcal meningitis: ethics and management].
    Fernández Fraga C
    Aten Primaria; 1998 Apr; 21(7):502, 504. PubMed ID: 9656594
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccination against meningococcal meningitis.
    Goldschneider I
    Conn Med; 1970 May; 34(5):335-9. PubMed ID: 5431940
    [No Abstract]   [Full Text] [Related]  

  • 3. [Meningococcal meningitis: preliminary epidemiological results on the introduction of a prophylactic vaccine].
    Galli MG
    G Batteriol Virol Immunol; 1982; 75(7-12):251-4. PubMed ID: 7188258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a meningococcal vaccine.
    Poolman JT
    Infect Agents Dis; 1995 Mar; 4(1):13-28. PubMed ID: 7728353
    [No Abstract]   [Full Text] [Related]  

  • 5. [Observation on the epidemiologic efficacy for 9 years on epidemic meningococcal polysaccharide vaccine of group A by district immunization method].
    Ma Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Apr; 12(2):69-71. PubMed ID: 2065343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Vaccination against meningitis.
    Br Med J; 1976 Apr; 1(6015):919-20. PubMed ID: 817764
    [No Abstract]   [Full Text] [Related]  

  • 7. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
    Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
    Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines against meningococcal meningitis: current status.
    Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
    Lepow ML; Gold R
    N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
    [No Abstract]   [Full Text] [Related]  

  • 11. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
    Xu CH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaccine research--88. Vaccination against infectious meningitis].
    Bjune G
    Sykepleien; 1988 Nov; 76(22):24-5. PubMed ID: 3212650
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 14. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status--meningococcal vaccine.
    Merchant R; Divekar R
    Indian J Pediatr; 1988; 55(2):256-60. PubMed ID: 3042624
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vaccination Project-88. New Norwegian vaccine against type B meningitis--what happened?].
    Rød KA
    Fag Tidsskr Sykepleien; 1990 Jan; 78(1):27-31. PubMed ID: 2109367
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa.
    Greenwood BM; Smith AW; Hassan-King M; Bijlmer HA; Shenton FC; Hughes AS; Nunn PP; Jack AD; Gowers PR
    Trans R Soc Trop Med Hyg; 1986; 80(6):1006-7. PubMed ID: 3603632
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tetravalent anti-meningococcal vaccine: serologic and clinical evaluation].
    Vescia N; Mastroeni I; Pompa MG; Signorelli C; Fara GM
    Ann Ig; 1989; 1(6):1293-8. PubMed ID: 2484465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccines against Neisseria meningitidis].
    Ferrón L; Criado MT; Ferreirós CM
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002
    [No Abstract]   [Full Text] [Related]  

  • 20. The implications of vaccines for prevention of bacterial meningitis.
    Riordan A
    Curr Opin Neurol; 2010 Jun; 23(3):319-24. PubMed ID: 20173637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.